logo
Plus   Neg
Share
Email

NTT Communications Offers Immediate Self-management Of Cloud, Network On Oct. 8

NTT Communications Corp. or NTTCom, the ICT solutions and international communications business within the Nippon Telegraph & Telephone Corp. or NTT (NTT), announced Wednesday that the customer portal of its Enterprise Cloud service will offer immediate on-demand management of cloud-connected Internet and VPN circuits. It will also offer cloud-based settings for server and network segments in virtual servers, beginning October 8.

In addition to adding/subtracting server resources, the service will enable changes in connected circuit bandwidth, the addition of network segments, and changes in VPN circuit-routing information. There will be no charge for these functions.

The company said the operation of cloud ICT infrastructure requires the cloud and network to be managed on a unified basis. In many cases, however, changes are not reflected immediately and cannot be centralized.

Until now, network operations within ICT infrastructure have been relatively burdensome in terms of workload and limited flexibility, unlike server resources. In the near future, however, Enterprise Cloud will enable enterprises to accelerate business expansion and reduce workload by directly managing network settings, including VPN and Internet circuits, as well as existing settings for items such as compute resources, storage and network machines such as firewalls, the company noted.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
MillerCoors LLC has filed a lawsuit against Anheuser-Busch Companies LLC, part of Anheuser-Busch InBev, alleging that Anheuser-Busch's ad campaigns associating MillerCoors' products, Miller Lite and Coor Light, with corn syrup is "false and misleading." During the Super Bowl, ABInBev ran an advertising campaign that mocked Miller Lite and Coors Light use corn syrup in brewing. Shares of Biogen Inc. are falling almost 28 percent in Thursday's trading after the company and Japanese drugmaker Eisai Co. said they will discontinue two late-stage trials for their experimental Alzheimer's drug, Aducanumab. The two Phase 3 trials, ENGAGE and EMERGE, are multi-center, randomized, double-blind, placebo-controlled, parallel-group studies designed to evaluate Aducanumab. The European Union on Wednesday ordered Alphabet Inc.'s Google to pay an antitrust fine of 1.49 billion euros for abusing its dominant position in the online search advertising intermediation market by preventing competition. This is the third antitrust fine by the EU against Google and it represents 1.29 percent of the tech giant's turnover in 2018.
Follow RTT